A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)

Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Ophthalmol Med
Autors principals: Eris, Erdem, Erdogan, Gurkan, Perente, Irfan, Demir, Gokhan, Kepez Yildiz, Burcin, Aygit, Ebru Demet
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643104/
https://ncbi.nlm.nih.gov/pubmed/29098101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/6369085
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars